Evidence map›Paper›PMID 40641983›Full record

ArticleFrontiers in medicine2025

RaNet: a residual attention network for accurate prostate segmentation in T2-weighted MRI.

Muhammad Arshad, Chengliang Wang, Muhammad Wajeeh Us Sima, Jamshed Ali Shaikh, Salem Alkhalaf, Fahad Alturise

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Muhammad ArshadCollege of Computer Science, Chongqing University, Shapingba, Chongqing, China.
Chengliang WangCollege of Computer Science, Chongqing University, Shapingba, Chongqing, China.
Muhammad Wajeeh Us SimaCollege of Computer Science, Chongqing University, Shapingba, Chongqing, China.
Jamshed Ali ShaikhCollege of Computer Science, Chongqing University, Shapingba, Chongqing, China.
Salem AlkhalafDepartment of Computer Engineering, College of Computer, Qassim University, Buraydah, Saudi Arabia.
Fahad AlturiseDepartment of Cybersecurity, College of Computer, Qassim University, Buraydah, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate segmentation of the prostate in T2-weighted MRI is critical for effective prostate diagnosis and treatment planning. Existing methods often struggle with the complex textures and subtle variations in the prostate. To address these challenges, we propose RaNet (Residual Attention Network), a novel framework based on ResNet50, incorporating three key modules: the DilatedContextNet (DCNet) encoder, the Multi-Scale Attention Fusion (MSAF), and the Feature Fusion Module (FFM). The encoder leverages residual connections to extract hierarchical features, capturing both fine-grained details and multi-scale patterns in the prostate. The MSAF enhances segmentation by dynamically focusing on key regions, refining feature selection and minimizing errors, while the FFM optimizes the handling of spatial hierarchies and varying object sizes, improving boundary delineation. The decoder mirrors the encoder's structure, using deconvolutional layers and skip connections to retain essential spatial details. We evaluated RaNet on a prostate MRI dataset PROMISE12 and ProstateX , achieving a DSC of 98.61 and 96.57 respectively. RaNet also demonstrated robustness to imaging artifacts and MRI protocol variability, confirming its applicability across diverse clinical scenarios. With a balance of segmentation accuracy and computational efficiency, RaNet is well suited for real-time clinical use, offering a powerful tool for precise delineation and enhanced prostate diagnostics.

Indexed as

deep learningfeature fusionmedical image segmentationprostate cancerRaNetrefine feature selection

Identifiers

PMID40641983
PMCPMC12241084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.